Cellulitis Completed Phase 2 Trials for Oritavancin (DB04911)

Also known as: Cellulitis, unspecified

IndicationStatusPhase
DBCOND0014773 (Cellulitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00514527A Study for Patients With Complicated Skin and Skin Structure InfectionsTreatment